A detailed history of Bartlett & Co. LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Bartlett & Co. LLC holds 175 shares of MEDP stock, worth $57,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175
Previous 75 133.33%
Holding current value
$57,925
Previous $18,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

BUY
$227.52 - $312.68 $22,752 - $31,268
100 Added 133.33%
175 $54,000
Q1 2022

May 13, 2022

BUY
$138.87 - $214.31 $10,415 - $16,073
75 New
75 $12,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Bartlett & Co. LLC Portfolio

Follow Bartlett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.